Coupons for Allergy and Asthma Medications - As Supplied by Manufacturer

Editor: V. Dimov, M.D., Allergist/Immunologist and Assistant Professor at University of Chicago

Asthma Medications (in alphabetical order)

Advair


Astepro


Antihistamines (pills)

Benadryl

Published: 01/22/2011
Updated: 11/09/2011

Labels: ,

Allergy to pomegranate (Punica granatum)

Author: V. Dimov, M.D., Allergist/Immunologist and Assistant Professor at University of Chicago
Reviewer: S. Randhawa, M.D., Allergist/Immunologist

Pomegranate (Punica granatum)

The pomegranate is the fruit of the Punica granatum, a tree native to southwest Asia and widely cultivated in the Mediterranean area. The pomegranate ripens in autumn and is consumed from September to December. The pulp of the fruit is composed of a cluster of fleshy, red-violet seeds.

Clinical features of pomegranate allergy

The first case ever reported of adverse reaction to pomegranate was in 1992 (J Investig Allergol Clin Immunol. 1992). In this case the researchers were unable to demonstrate an IgE-mediated mechanism (prick test, histamine release test and RAST with pomegranate were all negative). The history of tongue angioedema due to pomegranate intake was proven by a double blind oral challenge test. This report emphasizes the importance of clinical history and oral challenge test in the diagnosis of food allergy.

Several adverse reactions to pomegranate, including abdominal pain, itching, generalized urticaria, oropharyngeal pruritus and severe symptoms such as anaphylactic shock, bronchospasm, dyspnea, angioedema or laryngeal edema, have been described in recent years.

Polysensitization in patients allergic to pomegranate

In a study of 15 patients allergic to pomegranate, 13 had sensitivity to pollens, 10 to nuts, and eight to peach. Type I hypersensitivity was strongly suggested by the positivity of the skin prick test and demonstration of specifc IgE antibodies to pomegranate in some of the patient sera (custom made test by the investigators).

Diagnosis of pomegranate allergy

A prick-prick test (prick-puncture) with the fresh fruit can be useful in making the diagnosis of pomegranate allergy. Patients with pomegranate allergy are often sensitized to other allergens.

In-vitro tests in pomegranate allergy

A 29-kDa protein allergen has been identifed in this common Mediterranean fruit.

Lipid transfer proteins (LTPs) are a family of low molecular mass (7-9 kDa) polypeptides, the members of which share 35-95% sequence homology. These proteins are widely distributed throughout the plant kingdom and are receiving attention for their biochemical characteristics and biological activity.

The specific IgE testing for pomegranate has not been standardized as of year 2010, and is not currently commercially available.

Pomegranate should be considered a potential allergen in patients suffering anaphylaxis in autumn and living in countries where this fruit is consumed.

Treatment of pomegranate allergy

Persistent avoidance and epineprine as needed are the mainstays of management.

References

Isolation and identification of two lipid transfer proteins in pomegranate (Punica granatum). J Agric Food Chem. 2007 Dec 26;55(26):11057-62. Epub 2007 Nov 27.

Pomegranate (Punica granatum) allergy: clinical and immunological findings. Ann Allergy Asthma Immunol. 2009 Aug;103(2):178-80.

Allergy to pomegranate (Punica granatum). Allergy. 1999 Mar;54(3):287-8.

Allergy to pomegranate (Punica granatum). J Investig Allergol Clin Immunol. 1992 Jul-Aug;2(4):216-8.

Adverse reaction to pomegranate ingestion. Allergy. 1991 Aug;46(6):472-4.

ARUP Labs.

Published: 01/12/2011
Updated: 01/22/2011

Labels:

Anti-FceR1 Autoantibodies in Chronic Urticaria

Author: V. Dimov, M.D., Assistant Professor, Allergist/Immunologist, University of Chicago
Reviewer: S. Randhawa, M.D., Allergist/Immunologist, Fort Lauderdale, FL

Approximately 40% of patients with chronic idiopathic urticaria have antibodies to the alpha subunit of the high-affinity IgE receptor (FcεR1). In the patients, the cause of urticaria is not external; it is an autoimmune reaction. Patients with autoantibodies could be identified by histamine release assay, autologous serum skin tests and Western blot.


An antibody has Fab (fragment, antigen-binding) and Fc (fragment, crystalizable) regions. Fc receptors bind to the Fc region. Image source: Wikipedia, public domain.


Fc receptor interaction with an antibody-coated microbial pathogen. Image source: Wikipedia, public domain.



Anti-FceR1 autoantibodies in chronic autoimmune urticaria: IgG against FceRI (receptor for IgE) (click to enlarge the image).

CD203c is a basophil activation marker known to be upregulated by cross-linking of the Fc (epsilon) RI alpha receptor and may serve as a useful marker to identify these patients. CD203 is expressed specifically on basophils, mast cells and their CD34+ progenitor cells and is upregulated by cross-linking of the FcεR1.

Sera from patients with chronic urticaria significantly upregulate basophil CD203c expression as measured by flow cytometry. Activated basophils from whole blood are identified by flow cytometry on the basis of the presence of CD203c on high-expressing IgE positive cells. CD203c expression correlates with basophil histamine release and the size of the autologous serum skin test.

Test code: IGERAB (it can be ordered through the Mayo Clinic lab service). Reference Lab: Sent to National Jewish via Mayo Clinic.

Test description: Anti-Fce Receptor Assay. More info: Anti-IgE Receptor I antibody, anti-CD203c, Chronic urticaria assay.

Method: Flow Cytometry

Reference range: greater than 2%, or by report.

Specimen Required: Draw blood in a plain, red-top tube (serum gel tube is not acceptable). Allow blood to clot and separate within one hour. Send 1 mL of serum frozen.

Specimen requirements: 1 ml of serum

Transport requirements: Sera should be shipped frozen and received in the laboratory within 24 hours after drawing. Days test is performed: Mondays. Turn around time: 1 week.

CPT code: 88184, 88185

References

Chronic urticaria sera increase basophile CD203c expression. Yasnowsky KM, Dreskin SC, Efaw B, Schoen D, Vedanthan PK, Alam R, Harbeck RJ. J Allergy Clin Immunol 2006;117:1430-4.
Clinical Reference Laboratories at National Jewish info sheet (PDF).
Clinical Reference Laboratories at National Jewish - 2007 newsletter (PDF).

Published: 01/07/2011
Updated: 11/16/2011

Labels:

<body>